We maintain BUY call on Ancom Nylex (Ancom) with an unchanged fair value (FV) of RM1.43/share. This is pegged to a target FY24F PE of 14x, 0.75 standard deviation (SD) below its 5-year mean of 21x. No ESG-related FV adjustment based on an unchanged 3-star rating.
Pending an analyst briefing later today, we maintain our earnings forecasts for now given Ancom’s FY23 core net profit of RM74.9mil generally came in within expectations, 5% below our forecast and almost on the dot to street’s. In addition, we introduce FY26F earnings with a 26% YoY growth, mainly underpinned by capacity expansions for Product T (+1K MT/annum) and S (+500MT/annum).
A maiden interim dividend of 1.0 sen/share has been declared, implying FY23 payout of 12%, which beat our expectations given Ancom’s last dividend was paid in FY14. Nevertheless, we believe this could be one-off given the group’s continued capex-driven expansionary trajectory towards the introduction of new products T and S. We therefore maintain our zero dividend payout assumptions for FY24F-26F for now.
On a YoY basis, Ancom’s 4QFY23 revenue registered a decline of 15% to RM478mil from RM565mil in 4QFY22. Consequently, 4QFY23 core net profit decreased by 43% to RM17mil from RM29mil in 4QFY22. The weaker earnings were mostly related to the industrial chemicals segment, which experienced lower revenue (-21% YoY) and EBIT margin of 2.3% (-0.5ppt YoY) owing to lower average selling prices (ASP) and sales volume amid lower oil prices and weakening economic growth.
For the agrichemicals segment, 4QFY23 revenue decreased by 9% YoY, mainly due to lower ASP in tandem with lower prices of chemical intermediaries. However, the segmental EBIT improved 9% YoY due to lower operating expenses as a result of improved economies of scale in light of increased sales volume.
On a QoQ basis, Ancom’s 4QFY23 core net profit increased by 5% despite a 1% contraction in revenue. The weaker revenue was predominantly attributed to the agrichemicals segment (- 8% QoQ), that experienced reduced ASP. However, it was offset by a lower group effective tax rate of 5% (vs 26% in 3QFY23) thanks to better tax management.
Surprisingly, the industrial chemicals segment experienced a 7% QoQ growth in revenue, mainly driven by higher sales volume. Notably, EBIT improved by 54% QoQ, likely attributable to better cost management given a more stable oil price environment in 1H2023 compared to 2H2022.
Going into FY24F, we expect agrichemicals segment to benefit from: (a) the ban on paraquat in Thailand and Malaysia, (b) the shift in demand from expensive patented herbicides to cheaper generic versions amid global economic slowdown, (c) the commercialisation of Product T in Dec 2023, and (d) better oil price trajectory since late-Jun 2023 in line with our in-house 2023F oil price of US$83/barrel (vs US$80/barrel YTD-2023).
Similarly, the industrial chemicals segment should be stronger on higher ASP in light of a favourable oil price trajectory recently and stable sales volume given Ancom’s industrial chemicals segment mainly serves the ASEAN market, which IMF predicts will grow at a higher rate of 4.5% in 2023F vs 2.8% global economic growth.
The stock currently trades at an unjustified FY24F PE of 9.8x, half of its 5-year mean of 21x, for the largest agrichemical manufacturer in ASEAN.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....